GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (BOM:532637) » Definitions » Accounts Payable & Accrued Expense

Mangalam Drugs & Organics (BOM:532637) Accounts Payable & Accrued Expense : ₹0 Mil (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics Accounts Payable & Accrued Expense?

Mangalam Drugs & Organics's quarterly accounts payable & accrued expense increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹1,047 Mil) but then declined from Sep. 2023 (₹1,047 Mil) to Dec. 2023 (₹0 Mil).

Mangalam Drugs & Organics's annual accounts payable & accrued expense increased from Mar. 2022 (₹569 Mil) to Mar. 2023 (₹975 Mil) but then declined from Mar. 2023 (₹975 Mil) to Mar. 2024 (₹659 Mil).

Mangalam Drugs & Organics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Mangalam Drugs & Organics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics Accounts Payable & Accrued Expense Chart

Mangalam Drugs & Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 567.95 434.56 568.66 974.91 658.86

Mangalam Drugs & Organics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 974.91 - 1,047.43 - 658.86

Mangalam Drugs & Organics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Mangalam Drugs & Organics (BOM:532637) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (BOM:532637) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
BOM:531173 BOM:532878 BOM:524518 BOM:532384 BOM:530313 BOM:537536 NSE:VAISHALI BOM:524824 NSE:SOTAC BOM:531739 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
MANGALAM:India
Address
239, P. D’Mello Road, Rupam Building, 3rd Floor, Near General Post Office, Mumbai, MH, IND, 400001
Website
https://www.mangalamdrugs.com
Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. It is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise of sales in the Indian and overseas markets.

Mangalam Drugs & Organics (BOM:532637) Headlines

No Headlines